Header Logo

Connection

Zhizhuang Zhao to Phenylalanine

Back to Details
This is a "connection" page, showing publications Zhizhuang Zhao has written about Phenylalanine.
Zhizhuang Zhao
Connection Strength
0.189
Phenylalanine
  1. Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth. J Biol Chem. 2007 Feb 09; 282(6):3428-32.
    View in: PubMed
    Score: 0.071
  2. Identification of an acquired JAK2 mutation in polycythemia vera. J Biol Chem. 2005 Jun 17; 280(24):22788-92.
    View in: PubMed
    Score: 0.063
  3. Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera. Ann Hematol. 2015 Apr; 94(4):717-9.
    View in: PubMed
    Score: 0.031
  4. The Jak2 inhibitor, G6, alleviates Jak2-V617F-mediated myeloproliferative neoplasia by providing significant therapeutic efficacy to the bone marrow. Neoplasia. 2011 Nov; 13(11):1058-68.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.